Dr Boreham's Crucible: Imugene - FNArena.com
Tim Boreham highlights the prospects for cancer treatment biotech Imugene
Stay updated with breaking news from Jens Eckstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tim Boreham highlights the prospects for cancer treatment biotech Imugene
The ASX had a winning day today. The S&P/ASX200 gained 81.40 points or 1.13% to 7,268.10 and crossing above its 20-day moving average. Over the last five...
-- HAYA closes US$5M seed extension led by Humboldt Fund to advance the development of its anti-fibrotic lead program targeting Wisper, a cardiac long non-coding RNA -- HAYA Therapeutics, SA, a company
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Apollo Health Ventures announces the final closing of its second venture fund to build a portfolio of data-driven biotechnology and healthtech ventures aimed at extending human healthspan. The oversubscribed